Serum peptidome profiling for identifying pathological patterns in patients with primary nephrotic syndrome

Chinese Medical Journal

Volumn 125, Issue 24, 2012, Pages 4418-4423

  Huang, Lan Ting ^a   Wen, Qiong ^a   Zhao, Ming Zhe ^a   Li, Zhi Bin ^a   Luo, Ning ^a   Wang, Yong Tao ^a   Dong, Xiu Qing ^a   Yu, Xue Qing ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Diagnostic model; Matrix assisted laser desorption ionization time of flight mass spectrometry; Nephrotic syndrome; Serum

Indexed keywords

FIBRINOGEN; FIBRINOGEN A; PEPTIDOME; PROTEOME; UNCLASSIFIED DRUG;

ACCURACY; ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FOCAL GLOMERULOSCLEROSIS; GENETIC ALGORITHM; HUMAN; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEMBRANOUS GLOMERULONEPHRITIS; MINIMAL CHANGE GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; PROTEIN BLOOD LEVEL; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SERUM; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS;

ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; NEPHROTIC SYNDROME; PEPTIDES; PROTEOMICS; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; YOUNG ADULT;

EID: 84874300255     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2012.24.017     Document Type: Article

References (39)

1. Hull RP, Goldsmith DJ. Nephrotic syndrome in adults. BMJ 2008; 336: 1185-1189. (Pubitemid 351809281)
2. Traum AZ, Schachter AD. Urinary proteome profiling to search for biomarkers in steroid-resistant nephrotic syndrome. Contrib Nephrol 2008; 160: 29-36.
3. Orth SR, Ritz E. The nephrotic syndrome. N Engl J Med 1998; 338: 1202-1211. (Pubitemid 28180750)
4. Whittier WL, Korbet SM. Renal biopsy: update. Curr Opin Nephrol Hypertens 2004; 13: 661-665. (Pubitemid 39506916)
5. Whittier WL, Korbet SM. Timing of complications in percutaneous renal biopsy. J Am Soc Nephrol 2004; 15: 142-147. (Pubitemid 38020705)
6. Eiro M, Katoh T, Watanabe T. Risk factors for bleeding complications in percutaneous renal biopsy. Clin Exp Nephrol 2005; 9: 40-45. (Pubitemid 40576883)
7. Stiles KP, Yuan CM, Chung EM, Lyon RD, Lane JD, Abbott KC. Renal biopsy in high-risk patients with medical diseases of the kidney. Am J Kidney Dis 2000; 36:419-433. (Pubitemid 30485854)
8. Seigneux S, Martin PY. Management of patients with nephrotic syndrome. Swiss Med Wkly 2009; 139: 416-422.
9. Liotta LA, Ferrari M, Petricoin E. Clinical proteomics written in blood. Nature 2003; 425: 905.
10. Villanueva J, Shaffer DR, Philip J, Chaparro CA, Erdjument-Bromage H, Olshen AB, et al. Differential exoprotease activities confer tumor specific serum peptidome patterns. J Clin Invest 2006; 116: 271-284. (Pubitemid 43121812)
11. Pietrowska M, Polanska J, Marczak L, Behrendt K, Nowicka E, Stobiecki M, et al. Mass spectrometry-based analysis of therapy-related changes in serum proteome patterns of patients with early-stage breast cancer. J Transl Med 2010; 8: 66.
12. Musharraf SG, Hashmi N, Choudhary MI, Rizvi N, Usman A, Atta-Ur-Rahman. Comparison of plasma from healthy nonsmokers, smokers, and lung cancer patients: pattern-based differentiation profiling of low molecular weight proteins and peptides by magnetic bead technology with MALDI-TOF MS. Biomarkers 2012; 17: 223-230.
13. Gianazza E, Mainini V, Castoldi G, Chinello C, Zerbini G, Bianchi C, et al. Different expression of fibrinopeptide A and related fragments in serum of type 1 diabetic patients with nephropathy. J Proteomics 2010; 73: 593-601.
14. Kim JY, Song HJ, Lim HJ, Shin MG, Kim JS, Kim HJ, et al. Platelet factor 4 is an indicator of blood count recovery in acute myeloid leukemia patients in complete remission. Mol Cell Proteomics 2008; 7:431-441. (Pubitemid 351298454)
15. Xiao D, Zhao LJ, Chu SL, Jing H, Wang C. Proteomic analysis for detecting serum biomarkers related to smoking in humans. Chin Med J 2012; 125: 3027-3032.
16. Chinello C, Gianazza E, Zoppis I, Mainini V, Galbusera C, Picozzi S, et al. Serum biomarkers of renal cell carcinoma assessed using a protein profiling approach based on ClinProt technique. Urology 2010; 75: 842-847.
17. Mor G, Visintin I, Lai Y, Zhao H, Schwartz P, Rutherford T, et al. Serum protein markers for early detection of ovarian cancer. Proc Natl Acad Sci U S A 2005; 102: 7677-7682. (Pubitemid 40741030)
18. Tirumalai RS, Chan KC, Prieto DA, Issaq HJ, Conrads TP, Veenstra TD. Characterization of the low molecular weight human serum proteome. Mol Cell Proteomics 2003; 2: 1096-1103.
19. Du J, Yang S, Lin X, Bu L, Nan Y, Huo S. Use of anchorchip-time-of-flight spectrometry technology to screen tumor biomarker proteins in serum for small cell lung cancer. Diagn Pathol 2010; 5: 60.
20. Villanueva J, Lawlor K, Toledo-Crow R, Tempst P. Automated serum peptide profiling. Nat Protoc 2006; 1: 880-891.
21. Vitzthum F, Behrens F, Anderson NL, Shaw JH. Proteomics from basic research to diagnostic application: a review of requirements needs. J Proteome Res 2005; 4: 1086-1097. (Pubitemid 41208666)
22. Hsieh SY, Chen RK, Pan YH, Lee HL. Systematical evaluation of the effects of sample collection procedures on low molecular weight serum plasma proteome profiling. Proteomics 2006; 6: 3189-3198.
23. Albrethsen J. Reproducibility in protein profiling by MALDI TOF mass spectrometry. Clin Chem 2007; 53: 852-858. (Pubitemid 46744240)
24. Fiedler GM, Baumann S, Leichtle A, Oltmann A, Kase J, Thiery J, et al. Standardized peptidome profiling of human urine by magnetic bead separation and matrix assisted laser desorption ionization time of flight mass spectrometry. Clin Chem 2007;53:421-428. (Pubitemid 46447938)
25. Zhang Q, Li SZ, Feng CS, Qu XD, Wang H, Zhang XN, et al. Serum proteomics of early postoperative cognitive dysfunction in elderly patients. Chin Med J 2012; 125: 2455-2461.
26. Weissinger EM, Wittke S, Kaiser T, Haller H, Bartel S, Krebs R, et al. Proteomic patterns established with capillary electrophoresis and mass spectrometry for diagnostic purposes. Kidney Int 2004; 65: 2426-2434. (Pubitemid 38670029)
27. Varghese SA, Powell TB, Budisavljevic MN, Oates JC, Raymond JR, Almeida JS, et al. Urine biomarkers predict the cause of glomerular disease. J Am Soc Nephrol 2007; 18: 913-922. (Pubitemid 46434508)
28. Shui HA, Huang TH, Ka SM, Chen PH, Lin YF, Chen A. Urinary proteome and potential biomarkers associated with serial pathogenesis steps of focal segmental glomerulosclerosis. Nephrol Dial Transplant 2008; 23: 176-185. (Pubitemid 351767390)
29. Schwamborn K, Krieg RC, Grosse J, Reulen N, Weiskirchen R, Knuechel R, et al. Serum proteomic profiling in patients with bladder cancer. Eur Urol 2009; 56: 989-996.
30. Huang Z, Shi Y, Cai B, Wang L, Wu Y, Ying B, et al. MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of system. Rheumatology 2009; 48: 626-631.
31. Yoo BC, Kong SY, Jang SG, Kim KH, Ahn SA, Park WS, et al. Identification of hypoxanthine as a urine marker for non-Hodgkin lymphoma by low mass ion profiling. BMC Cancer 2010; 23: 10-55.
32. Picken MM, Linke RP. Nephrotic syndrome due to an amyloidogenic. J Am Soc Nephrol 2009; 20: 1681-1685.
33. Knepper MA. Proteomics and the kidney. J Am Soc Nephrol 2002; 13: 1398-1408. (Pubitemid 34441423)
34. Kasthuri RS, Verneris MR, Ibrahim HN, Jilma B, Nelsestuen GL. Studying multiple protein profiles over time to assess biomarker validity. Expert Rev Proteomics 2006; 3:455-464. (Pubitemid 44231987)
35. Check E. Proteomics and cancer running before we can walk. Nature 2004; 429:496-497. (Pubitemid 38737636)
36. Cheng AJ, Chen LC, Chien KY, Chen YJ, Chang JT, Wang HM, et al. Oral cancer plasma tumor marker identified with bead based affinity fractionated proteomic technology. Clin Chem 2005;51:2236-2244. (Pubitemid 41692565)
37. Hortin GL. The MALDI-TOF mass spectrometric view of the plasma proteome and peptidome. Clin Chem 2006; 52: 1223-1237. (Pubitemid 43956011)
38. Baumann S, Ceglarek U, Fiedler GM, Lembcke J, Leichtle A, Thiery J, et al. Standardized approach to proteome profiling of human serum based on magnetic bead separation and matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Chem 2005; 51: 973-980. (Pubitemid 40740877)
39. Bruegel M, Planert M, Baumann S, Focke A, Bergh FT, Leichtle A, et al. Standardized peptidome profiling of human cerebrospinal fluid by magnetic bead separation and matrix assisted laser desorption ionization time of flight mass spectrometry. J Proteomics 2009; 72: 608-615.